+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

China Biopharma Comparative Analysis Report - Product Thumbnail Image

China Biopharma Comparative Analysis Report

  • Report
  • December 2022
  • 56 Pages
  • China
Biologics Market Report 2024-2034 - Product Thumbnail Image

Biologics Market Report 2024-2034

  • Report
  • November 2023
  • 312 Pages
  • Global
From
Recombinant Proteins Market Report 2023-2033 - Product Thumbnail Image

Recombinant Proteins Market Report 2023-2033

  • Report
  • April 2023
  • 353 Pages
  • Global
From
From
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Therapeutic Biologics to 2026 - Product Thumbnail Image

Therapeutic Biologics to 2026

  • Report
  • January 2022
  • 120 Pages
  • Global
Biologic Therapeutic Drugs: Technologies and Global Markets - Product Thumbnail Image

Biologic Therapeutic Drugs: Technologies and Global Markets

  • Report
  • January 2024
  • 253 Pages
  • Global
From
From
From
From
Global Biopharmaceuticals Market Outlook to 2027 - Product Thumbnail Image

Global Biopharmaceuticals Market Outlook to 2027

  • Report
  • July 2023
  • 80 Pages
  • Global
From
From
From
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more